Human HS1BP3 induces cell apoptosis and activates AP-1 |
Shi, Taiping
(Laboratory of Medical Immunology, School of Basic Medical Science, Peking University Health Science Center)
Xie, Jieshi (Chinese National Human Genome Center) Xiong, Ying (Chinese National Human Genome Center) Deng, Weiwei (Chinese National Human Genome Center) Guo, Jinhai (Chinese National Human Genome Center) Wang, Feng (Chinese National Human Genome Center) Ma, Dalong (Laboratory of Medical Immunology, School of Basic Medical Science, Peking University Health Science Center) |
1 | Chen, Y. R., Kori, R., John, B. and Tan, T. H. (2001) Caspase-mediated cleavage of actin-binding and SH3-domaincontaining proteins cortactin, HS1, and HIP-55 during apoptosis. Biochem. Biophys. Res. Commun. 288, 981-989. DOI ScienceOn |
2 | Ensenat, D., Yao, Z., Wang, X. S., Kori, R., Zhou, G., Lee, S. C. and Tan, T. H. (1999) A novel Src homology 3 domain- containing adaptor protein, HIP-55, that interacts with hematopoietic progenitor kinase 1. J. Biol. Chem. 274, 33945-33950. DOI |
3 | Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A. and Davis, R. J. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870-874. DOI ScienceOn |
4 | Lei, K., Nimnual, A., Zong, W. X., Kennedy, N. J., Flavell, R. A., Thompson, C. B., Bar-Sagi, D. and Davis, R. J. (2002) The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol. Cell. Biol. 22, 4929-4942. DOI |
5 | Ham, J., Babij, C., Whitfield, J., Pfarr, C. M., Lallemand, D., Yaniv, M. and Rubin, L. L. (1995) A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14, 927-939. DOI ScienceOn |
6 | Estus, S., Zaks, W. J., Freeman, R. S., Gruda, M., Bravo, R. and Johnson, E. M. Jr. (1994) Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 127, 1717-1727. DOI |
7 | Bossy-Wetzel, E., Bakiri, L. and Yaniv, M. (1997) Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16, 1695-1709. DOI ScienceOn |
8 | Sawai, H., Okazaki, T., Yamamoto, H., Okano, H., Takeda, Y., Tashima, M., Sawada, H., Okuma, M., Ishikura, H., Umehara, H. and Domae, N. (1995) Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J. Biol. Chem. 270, 27326-27331. DOI ScienceOn |
9 | Higgins, J. J., Lombardi, R. Q., Pucilowska, J., Jankovic, J., Tan, E. K. and Rooney, J. P. (2005) A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology 64, 417-421. DOI ScienceOn |
10 | Fukuda, T., Kitamura, D., Taniuchi, I., Maekawa, Y., Benhamou, L. E., Sarthou, P. and Watanabe, T. (1995) Restoration of surface IgM-mediated apoptosis in an anti-IgM-resistant variant of WEHI-231 lymphoma cells by HS1, a protein-tyrosine kinase substrate. Proc. Natl. Acad. Sci. U.S.A. 92, 7302-7306. DOI |
11 | Yamanashi, Y., Fukuda, T., Nishizumi, H., Inazu, T., Higashi, K., Kitamura, D., Ishida, T., Yamamura, H., Watanabe, T. and Yamamoto, T. (1997) Role of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosis. J. Exp. Med. 185, 1387-1392. DOI ScienceOn |
12 | Muzio, M., Scielzo, C., Frenquelli, M., Bachi, A., De Palma, M., Alessio, M., Ghia, P. and Caligaris-Cappio, F. (2007) HS1 complexes with cytoskeleton adapters in normal and malignant chronic lymphocytic leukemia B cells. Leukemia 21, 2067-2070. DOI ScienceOn |
13 | Takemoto, Y., Furuta, M., Sato, M., Kubo, M. and Hashimoto, Y. (1999) Isolation and characterization of a novel HS1 SH3 domain binding protein, HS1BP3. Int. Immunol. 11, 1957-1964. DOI ScienceOn |
14 | Keeling, B. H., Vilariño-Güell, C., Ross, O. A., Wszolek, Z. K., Uitti, R. J. and Farrer, M. J. (2009) DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease. Neurosci. Lett. 461, 74-75. DOI ScienceOn |
15 | Deng, H., Le, W. D., Guo, Y., Huang, M. S., Xie, W. J. and Jankovic, J. (2005) Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease. Neurology 65, 651-652. DOI ScienceOn |
16 | Watabe, M., Ito, K., Masuda, Y., Nakajo, S. and Nakaya, K. (1998) Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene 16, 779-787. DOI |
17 | Ashida, R., Tominaga, K., Sasaki, E., Watanabe, T., Fujiwara, Y., Oshitani, N., Higuchi, K., Mitsuyama, S., Iwao, H. and Arakawa, T. (2005) AP-1 and colorectal cancer. Inflammopharmacology 13, 113-125. DOI ScienceOn |
18 | Fischer, U., Michel, A. and Meese, E. U. (2005) Expression of the gene for hematopoietic cell specific protein is not restricted to cells of hematopoietic origin. Int. J. Mol. Med. 15, 611-615. |
19 | Herdegen, T. and Waetzig, V. (2001) AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 20, 2424-2437. DOI |
20 | Angel, P., Szabowski, A. and Schorpp-Kistner, M. (2001) Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 20, 2413-2423. DOI |
21 | Matthews, C. P., Colburn, N. H. and Young, M. R. (2007) AP-1 a target for cancer prevention. Curr. Cancer Drug Targets 7, 317-324. DOI ScienceOn |